Summary:
We are conducting a Type 1 Diabetes research study evaluating the safety and efficacy of an investigational medication in newly diagnosed Type 1 Diabetes subjects.
Qualified Participants Must:
Be 20-45 years of age
Be diagnosed with Type 1 Diabetes for up to 5 months
Qualified Participants May Receive:
Eligible participants will receive up to $325 for time and travel.